Piperine, a piperidine alkaloid from Piper nigrum re-sensitizes P-gp, MRP1 and BCRP dependent multidrug resistant cancer cells
- 15 December 2011
- journal article
- Published by Elsevier BV in Phytomedicine
- Vol. 19 (1), 83-87
- https://doi.org/10.1016/j.phymed.2011.06.031
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- The beta‐carboline alkaloid harmine inhibits BCRP and can reverse resistance to the anticancer drugs mitoxantrone and camptothecin in breast cancer cellsPhytotherapy Research, 2009
- Lobeline, a piperidine alkaloid from Lobelia can reverse P-gp dependent multidrug resistance in tumor cellsPhytomedicine, 2008
- Recent Progress in Understanding the Mechanism of P-Glycoprotein-mediated Drug EffluxThe Journal of Membrane Biology, 2005
- Role of the breast cancer resistance protein (ABCG2) in drug transportThe AAPS Journal, 2005
- Microarray-based Detection of Multidrug Resistance in Human Tumor Cells by Expression Profiling of ATP-binding Cassette Transporter GenesCancer Research, 2004
- Analysis of ATP-Binding Cassette Transporter Expression in Drug-Selected Cell Lines by a Microarray Dedicated to Multidrug ResistanceMolecular Pharmacology, 2004
- Piperine, a Major Constituent of Black Pepper, Inhibits Human P-glycoprotein and CYP3A4The Journal of pharmacology and experimental therapeutics, 2002
- Mechanisms of Cancer Drug ResistanceAnnual Review of Medicine, 2002
- Reversal of Multidrug Resistance by the P-Glycoprotein Modulator, LY335979, from the Bench to the ClinicCurrent Medicinal Chemistry, 2001
- Potential usefulness of quinine to circumvent the anthracycline resistance in clinical practiceBritish Journal of Cancer, 1990